At Actor Pharmaceuticals, we are passionate about providing best-in-class specialty pharmaceuticals and biosimilar medicines to the healthcare industry, its professionals and patients.

Healthcare is our priority, and we focus on innovative products using the latest technologies and advancements to improve clinical outcomes and quality of life for patients.

This site is intended for Australian residents only.

Website links presented here are intended for use in Australia only and other countries may have different regulatory requirements and review practices that may require referencing different information.

To access product information and consumer medicine information, choose from the medicines below:

Prescription Medicines

ACTOBET® (calcipotriol and betamethasone gel) ▼
ANDRIGA-10® (abiraterone and prednisolone composite pack) ▼
AXHIDROX® (glycopyrronium bromide cream) ▼
KLISYRI® (tirbanibulin ointment) ▼
WYNZORA® (calcipotriol and betamethasone cream) ▼

Actor Pharmaceuticals Supply Notices:
Information regarding product supply, including medicines shortages and discontinuations can be found on the TGA Medicines Shortages Information Initiative website by clicking here.

PBS Information:
Klisyri® is not listed on the PBS.
Actobet®, Andriga-10®, Axhidrox® and Wynzora® are listed on the PBS. Refer to www.pbs.gov.au for full authority information.

Please review the Product Information before prescribing at www.tga.gov.au.

©2026 Actor Pharmaceuticals Pty Ltd. Klisyri® is a registered trademark and under license by Almirall, S.A. Actobet® and Andriga-10® are registered trademarks of Actor Pharmaceuticals Pty Ltd. Axhidrox® is a registered trademark of Dr. August Wolff GmbH & Co. KG Arzneimittel. Wynzora® is a registered trademark and PAD Technology™ is a trademark of MC2 Therapeutics Pty Ltd. All rights reserved 07/26